What You Should Know:
- ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, enabling data capture from home—where the device is intended to be used.
- Mi-Helper has been developed to meet a massive unmet need for effective, targeted, and drug-free pain management of migraines, a condition which impacts 1 billion
Read More
Zus Health Raises $40M, Partners with Primary Care EHR Elation
What You Should Know:
- Zus Health, (pronounced "Zoose"), a next-generation shared health data platform bringing distributed patient data directly to the point of care, announced today that the company has closed a $40 million financing from JAZZ Venture Partners, F-Prime Capital, Maverick Ventures, and Andreessen Horowitz (a16z).
- Zus is the only shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data at the
Read More
PointClickCare Acquires Value-Based Care EHR Patient Pattern
What You Should Know:
- PointClickCare Technologies, a healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of Patient Pattern. Financial terms of the transaction were not disclosed.
- The combination of PointClickCare and Patient Pattern will further the companies’ shared vision of enabling better care and outcomes for high-needs populations and provide
Read More
Lucid Hearing and Independa Launch World’s First Smart TV-Based Hearing Assessment on LG Smart TVs
What You Should Know:
- Lucid Hearing, a provider of holistic hearing healthcare, and Independa, an award-winning software platform providing remote engagement, education, and care, today announced the launch of the world's first smart TV-based hearing assessments. The announcement marks the first-of-a-kind offering to improve accessibility and promote better hearing health for all Americans.
- The partnership's breakthrough technology is
Read More
Orbita and Isabel Healthcare Integrate to Deliver ‘Find Care’ Search & Symptom Triage to Streamline Patient Access
What You Should Know:
- Orbita, a provider of virtual assistants for healthcare, announced a partnership with Isabel Healthcare that will improve patients’ digital experiences, helping them find the right care for their individual health circumstances. Isabel’s Symptom Checker/Triage utilizes every-day language to help patients access appropriate care with the right urgency.
- Many people who turn to technology when looking for a
Read More
Steps for Preventing Medical Malpractice Risks
Doctors and other healthcare professionals are entrusted with the responsibility of safeguarding the health and well-being of their patients, ensuring they receive the highest quality of care. While healthcare professionals are expected to provide a certain standard of care, any deviation from that standard that results in harm or injury to a patient may leave them exposed to a medical malpractice claim.
The consequences of medical malpractice can be severe, and in some cases, can result in
Read More
Pfizer Acquires Seagen for $43B to Tackle Cancer
What You Should Know:
- Pfizer announced it will acquire biotechnology company Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion. The proposed combination enhances Pfizer’s position as a leading company in Oncology.
Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio.
Seagen Background
Seagen is a pioneer in ADC technology, with
Read More
Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B
What You Should Know:
- Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of approximately $2.9B.
- The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet
Read More
Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients
Today, food insecurity affects more than 41 million Americans and is prevalent among children and the elderly population. Food insecurity is defined as the limited availability of nutritionally adequate and safe food or the inability to acquire these foods in socially acceptable ways. As a result, food insecurity can exacerbate medical conditions driving up hospital/health systems patient care costs. To learn more about how healthcare providers can address food insecurity, we sat down with Dr.
Read More
Drug Development: Allucent Expands Use of Medidata Clinical Cloud
What You Should Know:
- Medidata announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering.
- The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM,
Read More
